Centrexion Therapeutics (Centrexion Therapeutics) ROCE % : 0.00% (As of Sep. 2018)

View and export this data going back to 2018. Start your Free Trial

What is Centrexion Therapeutics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Centrexion Therapeutics's annualized ROCE % for the quarter that ended in Sep. 2018 was 0.00%.

Centrexion Therapeutics ROCE % Historical Data

The historical data trend for Centrexion Therapeutics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centrexion Therapeutics ROCE % Chart

Centrexion Therapeutics Annual Data

Trend

Dec16

Dec17

ROCE %

-186.16

-58.38

Centrexion Therapeutics Quarterly Data
	Dec16	Dec17	Sep18
ROCE %	-	-50.41	-

Centrexion Therapeutics ROCE % Calculation

Centrexion Therapeutics's annualized ROCE % for the fiscal year that ended in Dec. 2017 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2017 )		(A: Dec. 2016 )		(A: Dec. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2017 )		(A: Dec. 2016 )		(A: Dec. 2017 )
	=	-24.072	/	( ( (24.006 - 4.912)	+	(68.337 - 4.971) )	/ 2 )
	=	-24.072	/	( (19.094	+	63.366)	/ 2 )
	=	-24.072	/	41.23
	=	-58.38 %

Centrexion Therapeutics's ROCE % of for the quarter that ended in Sep. 2018 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2018 )		(Q: Dec. 2017 )		(Q: Sep. 2018 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2018 )		(Q: Dec. 2017 )		(Q: Sep. 2018 )
	=	0	/	( ( (68.337 - 4.971)	+	(52.786 - 5.903) )	/ 2 )
	=	0	/	( ( 63.366	+	46.883 )	/ 2 )
	=	0	/	55.1245
	=	0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2018) EBIT data.

Centrexion Therapeutics (NAS:CNTX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Centrexion Therapeutics ROCE % Related Terms

Thank you for viewing the detailed overview of Centrexion Therapeutics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.